絞り込み

16548

広告

Vonoprazan versus proton pump inhibitors for the management of gastroesophageal reflux disease: A protocol for a systematic review with meta-analysis.

著者 Kang H , Kim BJ , Choi G , Kim JG
Medicine (Baltimore).2018 Sep ; 97(39):e12574.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (73view , 0users)

Full Text Sources

Vonoprazan, a novel potassium-competitive acid blocking agent, is used in the management of gastroesophageal reflux disease (GERD). We aim to perform a systematic review and meta-analysis for the comparison of the effects of vonoprazan and proton pump inhibitors (PPIs) in GERD in randomized controlled trials (RCTs).
PMID: 30278564 [PubMed - in process]
印刷用ページを開く Endnote用テキストダウンロード